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Cancer is characterized by somatic mutations 
that provide a growth and survival advan-
tage. The mutations are a function of chance 
because of the random nature of mutagenesis. 
However, the biology in the tumor cells drives 
the selection of mutations that are advanta-
geous to the cancer.1 in addition, the tumor 
environment exerts a selective pressure on 
the tumor. For example, the hypoxic environ-
ment of a tumor induces HiF, stimulating veGF 
production, which signals to the non-tumor 
endothelial cells to stimulate angiogenesis. 
witkiewicz et al. have assessed the association 
of another non-tumor marker, MCT4, in triple-
negative breast cancer (TnBC).2
Triple-negative breast cancers are estro-
gen and progesterone receptor-negative 
and HeR-2-negative and account for 10–20% 
of all breast cancers.3 standard treatment is 
surgery with radiotherapy and adjuvant che-
motherapy, sometimes with biologic agents. 
Although TnBCs are generally very susceptible 
to chemotherapy, they are often associated 
with a shorter median time to relapse and 
early death. One important goal is to identify 
prognostic biomarkers to reliably select high- 
and low-risk subsets of TnBC.
Prognostic biomarkers do not have to be 
limited to the tumor cell. The ratio of tumor 
to stroma in TnBC is a predictor of outcome; 
tumors with < 50% stroma have a 5-year pro-
gression-free survival and overall survival of 
85% and 89% compared with 45% and 65% 
in tumors with >  50% stroma.4 Does the biol-
ogy of the stroma predict response in TnBC? 
Loss of stromal caveolin-1 (Cav-1) is predictive 
in TnBCs; 75.5% of patients are alive at 5 y 
with high stromal Cav-1 compared with 9.4% 
of patients with low stromal Cav-1.5 There is 
some controversy; not all data supports the 
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prognostic association, with arguments that 
Cav-1 is a tumor suppressor in some situations 
and an oncogene in other settings.6 Loss of 
Cav-1 increases the levels of enzymes in gly-
colysis and lactate dehydrogenase. Hence, the 
intracellular levels of lactate could be elevated 
in Cav-1-null stromal cells, and the level of the 
lactate transporter MCT4 could be increased 
to maintain intracellular pH.7 An inverse cor-
relation between Cav-1 and MCT4 expression 
is a plausible hypothesis. witkiewicz et al. 
showed high stromal MCT4 predicts for poor 
outcome in TnBC.2 Combining the data for 
both Cav-1 and MCT4 improved the prognos-
tic power of the data, certainly for the interme-
diate risk groups.
MCT4 is a plausible therapeutic target 
whether considering excessive production 
of lactate by stromal tissue or tumor cells. 
in either scenario, the metabolism of the 
tumor would be disturbed, causing intracel-
lular acidosis if MCT4 is on the tumor cells 
and starving the tumor if MCT4 is on the 
stromal cells. would patients with TnBC with 
Cav-1 low/MCT4 high stromal tissue elicit a 
clinical benefit from decreasing the availabil-
ity of lactate? Possibly. However, the tumor 
metabolism might adapt to use alternative 
sources of carbon. On the upside, the acidosis 
in the MCT4-positive stromal cells might kill 
the stromal cells, lowering the stroma/tumor 
ratio and subsequently extending relapse-
free survival.
The characterization of the cancer-stromal 
relationship is gaining momentum, from direct 
interactions, e.g., through integrins, to signal-
ing molecules such as veGF..8 Metabolically, 
chronic lymphocytic leukemia cells can modu-
late their redox status through the synthesis 
of GsH from cysteine that is released by bone 
marrow stromal cells.9 The bone marrow cells 
are not bystanders but import cystine and 
convert it to cysteine that is exported to the 
microenvironment.
in conclusion, there is crosstalk at multiple 
levels between tumor cells and the stroma, 
providing a rationale to target the stroma. 
This is unlikely to be a panacea for treating 
cancer as shown by the inter- and intra-tumor-
type heterogeneity that has been shown for 
tumor-stroma interactions. what will predict 
which tumors will respond to stroma directed 
therapies; the biology of the stroma, the biol-
ogy and genetics of the tumor or both? As 
the volume of cancer genome data grows, we 
would be wise to consider how the genetics 
of tumors is molded by the microenvironment 
and vice versa, and how we might target the 
microenvironment for clinical benefit.
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Cytokinesis is the final stage of cell division, 
during which physical separation of the two 
daughter cells is accomplished. it starts with 
ingression of the plasma membrane mediated 
by an actomyosin contractile ring leading to 
the formation of a cleavage furrow. By the end 
of furrowing, the dividing cells are connected 
by an intercellular microtubule-loaded bridge 
containing the midbody. During the final 
phase of cytokinesis, in a process called abscis-
sion, this bridge is severed, and two daughter 
cells are formed. Cells that have problems at 
this stage maintain the intercellular bridge for 
a prolonged period of time, and if the bridge 
cannot be severed, cells become polyploid. 
Polyploidy has been shown to promote tumor 
development.1
Central players in abscission are the mem-
bers of the esCRT (endosomal sorting complex 
required for transport) machinery, which con-
strict the intercellular bridge to allow its fis-
sion.2 These factors are recruited to the site of 
abscission by a protein named CeP55.3 CeP55’s 
function, in turn, is regulated by phosphory-
lation, and the phosphorylation-dependent 
peptidyl-prolyl isomerase Pin1.4 Pin1 is a mem-
ber of the parvulin family of prolyl isomerases 
that catalyze cis-trans isomerization of proline 
amide bonds. Another family of peptidyl-pro-
lyl isomerases are the cyclophilins. Generally, 
these isomerases control the folding/confor-
mation of proteins.
in a new study, Bannon et al. reported 
their analysis of the whereabouts and func-
tions of one of the cyclophilins, cyclophilin A 
(CypA, also called peptidyl-prolyl isomerase A) 
during cell division.5 They demonstrate that 
CypA is a centrosomal protein during inter-
phase and mitosis, and that it translocates to 
the midbody during cytokinesis. Although 
CypA is centrosomal, CypA deficiency does 
not cause any detectable mitotic abnormali-
ties. Bipolar spindle formation, the spindle 
assembly/mitotic checkpoint and the time 
taken from anaphase until furrow ingression 
in telophase are all comparable in CypA-
knockout and control cells, indicating that its 
function at the centrosome, if any, is at least 
redundant. However, knockdown or knockout 
of CypA does cause a defect at a later stage, 
namely during cytokinesis. More specifically, 
cells lacking CypA remained connected by 
a thin cytoplasmic intercellular bridge for a 
prolonged period of time and displayed a 
higher number of polyploid cells as compared 
with control cells. Moreover, CypA-deficient 
cells exhibit supernumerary centrosomes and 
decreased proliferation. By using a mutant of 
CypA (R55A) that has compromised isomer-
ase activity, the authors showed that isom-
erization activity of CypA is not required for 
its localization to the intercellular bridge 
but is essential for successful completion of 
cytokinesis.
An interesting area for further studies may 
include the identification of substrates of CypA 
that control cytokinesis. To this end, data-
base mining for the CypA consensus binding 
motif FGPXLP could be informative.6 in this 
motif, only the amino acids FGP are very strict. 
Another, complementary, approach to iden-
tify CypA substrates would be to search for 
interaction partners of CypA that are known 
to play a role in cytokinesis. notably, cells that 
have reduced activity of calcineurin, a het-
erodimeric protein phosphatase that interacts 
with CypA and does contain a CypA consensus 
binding motif, display cytokinesis defects that 
are similar to those seen in CypA-knockdown 
cells.7,8 Moreover, cyclosporine A (CsA), a fun-
gal immunosuppressive compound that can 
inhibit both calcineurin and CypA, induces a 
cytokinesis defect.8 interestingly, CypA may 
stimulate calcineurin activity.7 whether this is 
dependent on isomerase activity remains an 
open question. nevertheless, it is tempting to 
speculate that CypA may regulate cytokinesis 
through activation of calcineurin.
Peptidyl-prolyl isomerization plays a cru-
cial role in a plethora of cellular processes, 
and the results of Bannon et al. together with 
previously published data suggest that at 
least two isomerases, CypA and Pin1, regulate 
cytokinetic abscission.4,5 interestingly, in yeast, 
the loss of ess1 (yeast Pin1) can be com-
plemented by enhanced expression of CPH1 
(CypA), suggesting that Pin1 substrates can 
be isomerised by CypA9. However, it appears 
that in mammalian cells, they are not acting 
redundantly, as knockdown/knockout of each 
individually (Pin1 or CypA) results in a cytoki-
nesis defect.4
CypA is overexpressed in multiple cancers, 
and it has been hypothesized that tumor cells 
exploit protein isomerization to promote their 
growth. indeed, CypA deficiency does affect 
cell division and thus may be used as a thera-
peutic target to limit the proliferation of tumor 
cells.
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Meiosis represents a fundamental process 
involved in the formation of haploid gametes 
from diploid cells during sexual reproduction 
of eukaryotic organisms. it was discovered 
in the second half of 19th century and, after 
pioneering studies of Thomas H. Morgan in 
the 1910s, has become a hot topic of countless 
genetic studies. in spite of more than a cen-
tury’s worth of research on meiosis, many of its 
crucial features remain unknown. For example, 
one of the highlights of first meiotic division 
(meiosis i) is resistance of centromeric cohesion 
to cleavage by separase. Although it is clear 
that this is an essential prerequisite for success-
ful segregation of homologous chromosomes, 
its molecular nature is not fully understood.1 A 
model organism particularly suitable for inves-
tigating meiosis-related molecular mechanisms 
is fission yeast Schizosaccharomyces pombe. 
vegetative diploid cells of this yeast readily 
undergo meiotic program when starved for 
nitrogen and (unlike budding yeasts) produce 
ordered tetrads that allow direct determina-
tion of segregation during the first and second 
meiotic divisions. However, as investigations 
of events accompanying meiosis require 
highly synchronous cell populations, naturally 
sporulating cells exhibiting a low level of syn-
chrony are not suitable for systematic analyses. 
For more than two decades, these studies 
relied on the use of thermosensitive pat1–114 
allele. The wild-type pat1+ gene encodes pro-
tein kinase Pat1/Ran1, which negatively con-
trols the initiation of meiosis.2-4 Upon induction 
at non-permissive temperature, nitrogen-starv-
ing pat1–114/pat1–114 cells progress through 
the meiotic program in a highly synchronous 
manner. Although the meiosis in the pat1–114 
mutant is similar to that of wild-type cells, 
non-permissive temperature itself has adverse 
effects. For example, the cells cultivated at 
elevated temperature exhibit aberrant centro-
mere positioning, chromosome missegrega-
tion, substantial reduction of recombination 
and poor viability of spores (Fig. 1). Therefore, 
synchronizing meiotic cells at physiological 
temperature is highly desired. To address this 
problem, Cipak et al.5 and Guerra-Moreno et al.7 
took advantage of chemical genetics. They 
used an approach based on conditional inac-
tivation of target protein kinase by cell-perme-
able ATP analogs (1-nM-PP1 and 3-MB-PP1).6,8,9 
Cipak et al.5 constructed the pat1-as2 (ATP ana-
log-sensitive) allele coding for the Pat1 kinase 
with altered ATP-binding pocket. The mutant 
kinase Pat1(L95A) can be easily inactivated 
by addition 1-nM-PP1 to cultivation media, 
enabling the induction of the meiotic program 
at physiological temperature. As expected, 
the level of synchrony in the pat1-as2 popu-
lation is similar to pat1–114 cells cultivated 
at non-permissive temperature. importantly, 
the use of ATP analog-sensitive alleles elimi-
nates some of the abnormalities observed at 
elevated temperature. Moreover, the authors 
further improved their experimental system by 
combining the pat1-as2 allele with activating 
pheromone signaling by ectopic expression of 
both mating-type loci. This improved fidelity 
of chromosome segregation, spore viability as 
well as recombination to levels similar to that 
observed in the wild-type cells (Fig. 1). Guerra-
Moreno et al.7 synchronized meiosis using the 
Pat1(L95G) mutant that can be inactivated by 
3-MB-PP1. Moreover, they found that induced 
cells exhibit similar meiosis-related transcrip-
tion events as the pat1–114 strain (except for 
the transcription pattern of the stress response 
Figure 1. induction of synchronous meiotic cultures at physiological temperature. The standard procedure4 for obtaining synchronous meiotic 
cultures employs a temperature-sensitive allele (pat1–114) of the negative regulator of meiosis, protein kinase Pat1. However, due to the increased 
temperature the cells undergoing meiosis exhibit several abnormalities (in red). Cipak et al.5,6 prepared an ATP analog (1-nM-PP1) sensitive version 
of Pat1 [Pat1(L95A)] that can be inhibited at physiological temperature. when Pat1(L95A) carrying strain also contained ectopically expressed mat-Pc 
the authors observed a substantial improvement in most of the analyzed characteristics of meiosis (in green). in a similar study, Guerra-Moreno et al.7 
synchronized meiotic cells by inactivating of Pat1(L95G) mutant by another ATP analog (3-MB-PP1).© 2012 Landes Bioscience.
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Genomic instability and accumulation of muta-
tions is one of the features of cancer. in order 
to preserve genome integrity, cells require 
several evolutionary conserved processes, 
such as the DnA damage response and cell 
cycle checkpoints.1 in fact, the DnA damage 
response has been proposed to constitute an 
earlier barrier to tumorigenesis.2,3 However, the 
mechanism(s) by which cells maintain genome 
integrity, in particular a diploid complement, 
remain poorly understood.
in a previous issue of Cell Cycle, Bunz and 
colleagues set out to investigate the role of 
Chk1 in the preservation of stable ploidy.4 Using 
isogenic colorectal cancer cell lines that differ 
in p53 status, the authors generated cell lines 
hemizygous for CHK1 (homozygous CHK1-null 
cells are not viable) and show that CHK1 haploin-
sufficiency in a p53-deficient background leads 
to the appearance of a tetraploid subpopula-
tion.4 interestingly, CHK1 haploinsufficiency led 
to tetraploidization via mitotic bypass and sub-
sequent whole-genome endoreduplication.4
Chk1 is a ser/Thr kinase essential for cell 
viability, possibly through its role in monitor-
ing the proper execution of DnA replication 
and mitosis.5 However, the role of Chk1 in 
these processes is still unclear. Hints of its 
role have emerged in experiments following 
exogenous DnA damage stimuli. Under these 
conditions, the upstream kinase ATR rapidly 
activates Chk1, which, in turn, will phosphory-
late numerous downstream substrates pro-
moting the coordination of DnA repair with 
cell cycle progression.5,6
in unperturbed cells, Chk1 can also be found 
associated with chromatin and phosphorylates 
Thr11 in histone H3, leading to its acetylation at 
Lys9, a mark of transcriptionally active regions.7 
Upon DnA damage, Chk1 disengages from 
chromatin with two main consequences: a 
decrease of histone H3 phosphorylation, lead-
ing to repression of transcription of key cell 
cycle regulators,7 and an increase of inhibitory 
phosphorylations of CDC25, a positive regula-
tor of cell cycle progression.8 This one-two 
punch highlights the central role of Chk1 in 
regulating cell cycle progression.
Three main mechanisms have been pro-
posed to explain tetraploidization in cancer: 
cell fusion, defects in mitosis and endoredu-
plication.9 endoreduplication has been attrib-
uted to persistent ATM/ATR-mediated DnA 
damage signaling resulting from telomere 
dysfunction, DnA repair defects or oncogene 
overexpression.9 Bunz and colleagues now 
propose a distinct mechanism to achieve 
tetraploidization: high frequency of mitotic 
bypass due to decreased CHK1 gene dosage in 
p53-deficient cells. The authors demonstrate 
that this phenotype is ATR-independent and 
likely not due to DnA damage-induced effects. 
in fact, endogenous DnA damage levels, as 
judged by 53BP1 and phospho-H2AX nuclear 
foci formation, were similar in CHK1+/− and 
parental cells, showing that decreased levels 
of Chk1 by itself do not lead to a substantial 
increase in DnA damage.4
so, what mediates mitotic bypass caused 
by  CHK1 haploinsufficiency? Because Cdk1 
(also known as cdc2) has been shown to con-
trol entry to mitosis, the authors hypothe-
sized that normal levels of Chk1 might be 
required for full activation of Cdk1. indeed, 
in p53-deficient CHK1+/− cells, Cdk1 activity 
was diminished when compared with parental 
p53-deficient  CHK+/+ cells. Moreover, stable 
overexpression of Cdk1 in a p53-deficient 
CHK1+/− background suppressed the formation 
of tetraploid cells. whether the observed effect 
of CHK1 haploinsufficiency on Cdk1 activity is 
direct or not awaits further investigation.
in summary, the study by Bunz and col-
leagues shows that CHK1 haploinsufficiency 
may play an important role in tumorigenesis by 
promoting genetic instability in cells that are 
p53-deficient. This work opens up a new front 
in the study of mechanisms of mitotic bypass 
and highlights the power of genetic analysis 
using somatic knockout approaches. The Bunz 
laboratory has made seminal contributions 
to the development of these methods and is 
particularly well positioned to make further 
inroads into these difficult-to-tackle problems.
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gene hsp9 probably due to cultivation of the 
pat1–114 mutant at elevated temperature).
in summary, both reports5,7 further 
strengthened the advantages of fission yeast as 
the workhorse in cell biology. The experimental 
tool they developed for synchronization of 
entire cell populations at nearly physiological 
conditions provides a promising venue for 
upcoming discoveries in the field of meiosis.
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